NFE2L2 and carcinoma: In carcinomas harboring a KEAP1 mutation, immunohistochemical analysis showed increased expression of Nrf2 in comparison with normal parenchyma, suggesting a decreased inhibitory effect of Keap1 on Nrf2 (43).